Replies to post #88851 on Biotech Values

[DewDiligence]

IDIX:

Don't they have to enroll more patients as the trials progress so the cost might increase?

The treatment and follow-up period in these trials is relatively short, so the total number of patients enrolled at any given time will not increase by much.